Iterum Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Iterum Therapeutics (ITRM) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Iterum Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iterum Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Iterum Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.8k | 4.9k | 1.97 |
| 2023-06-30 | $51 | 48 | 1.06 |
| 2023-03-31 | $6 | 6 | 1.00 |
| 2022-12-31 | $13k | 15k | 0.84 |
| 2022-09-30 | $13k | 8.3k | 1.56 |